T1	Participants 10 58	rheumatoid arthritis patients of Shen deficiency
T2	Participants 63 95	cold invading syndrome by bushen
T5	Participants 580 646	control group (120 cases) were treated with MTX (10 mg/week) alone
T3	Participants 423 559	RA patients of Shen deficiency and cold invading syndrome in the treatment group (120 cases) were treated with BQZD and MTX (10 mg/week)
T4	Participants 1881 1957	effective herb for RA patients of Shen deficiency and cold invading syndrome
